We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

2-Year Patent Extension For Levaquin Sticks

Law360 (May 4, 2009, 12:00 AM EDT) -- A federal judge has upheld a two-year extension for Japanese drugmaker Daiichi Pharmaceutical Co.'s Levaquin patent, rejecting an effort by Lupin Ltd. to launch a generic version of the anti-bacterial blockbuster...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.